Together, our results indicated that compounds 4 and 6 may have strong anti-cancer properties that confer their effects either by directly interacting with cytokines (IL-6, IL-10), TNF-α, and TGF-β or via different axes such as MDM2/P53 and/or FAK/EZH2. This evidence concerns the gene TGFB1 and cancer.